By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Clara Campàs Moya, Co-Founder of Asabys Partners
by
April 19, 2021
reviewed by

DTx Solutions Leverage the Power of Gamification to Motivate Users

With 20 years of experience in the pharmaceutical industry, Clara Campàs Moya understands the healthcare market inside and out. In her view, after decades of impressive progress in medical sciences, it's time for healthcare and pharma companies to become more patient-centric.

Digital technologies can trigger the shift from an antiquated, uncoordinated healthcare infrastructure to one that is based on personalized treatment plans uniquely tailored to an individual's needs.

Gamification for Patients and Return on Investment for Payers

Once you explore the data and available studies, you start believing in how digital therapeutics can transform the quality of care.

Digital therapeutics (DTx) that are clinically validated and comply with regulatory conditions, can have a significant impact on patient well-being and chronic patient therapies. They boost motivation and engagement and can improve measurable indicators like compliance and medication adherence.

“For the patient living with a disease day by day, it’s incredibly demanding to follow various recommendations. Sometimes the treatment depends not only on taking pills but on rethinking their lifestyle. When gamification elements help people make small, healthy decisions and actions, it's already a big win for individuals," according to Clara.

Every patient has their own perception of illness and needs personalized support. Every incentive, guideline, and piece of feedback that shows whether you are staying on track impacts the behavior. DTx harnesses this power, offering a completely new experience.

This modern approach to healthcare employs patient engagement, which is beneficial for patients, payers, health providers, and the healthcare system.

Take, for instance, the patient journey. For the first time, everybody has a chance to follow up on the treatment or prevention outcomes in real-time. By installing an app and logging into the platform, individuals can manage their disease.

The existing transactional model in healthcare must be remodeled. Health insurers, public or private, want to know if what they are paying for brings true value to the patient. This is not surprising – health expenditures are rising rapidly, disproportionately to the outcomes.

Clara claims that present healthcare challenges force the reinvention of reimbursement strategies. DTx can help to capture and monitor the actual effects of the treatment.

“I observe many health insurance companies raising their hands and saying ‘check.’ They want to make the best of the limited amount of money they have. And most importantly, the savings from this value-oriented and rational management of resources go back to the patient.”

Want to learn more about implementing digital-first health solutions?

Learn more
Blue superhero Sidekick encouraging people to connect with us.

Sidekick Empowers Patients

Clara is convinced that the potential advantages of a DTx solution have been built into the Sidekick platform. “When we invest, we always aim to improve patients’ health. And Sidekick is ready to co-accomplish this mission. I was surprised by their mature business philosophy. The team is eager to address one of the biggest healthcare challenges, which is behavior change. They managed to build something which is clinically validated and scalable across different therapeutics platforms.”

Clara points out that, unlike many novel technologies, it’s not a nice to have fancy tool. This product is designed to meet the needs of users and help them prevent or manage chronic health conditions. And all this while maintaining the highest privacy and data security standards.

What fascinates me most is the improved clinical outcomes of patients using DTx versus patients treated in a classic manner. The fact that the patient can switch their self-perception is crucial. It’s much more meaningful than a technology that only reminds you to take a pill.

“I think it's great that Sidekick is focusing on the complex value chain as they scale up the solution. The platform integrates all components of healthcare into one seamless care continuum. We’ve reviewed over 100 digital therapeutics companies in the last couple of years. Sidekick has what is needed to make a change in healthcare: vision, team, technology, strategy, determination.”

Healthcare in the future will be substantially different. What was unbelievable before the COVID-19 pandemic is routine today. Telecare and remote patient monitoring have helped millions of patients while saving lives and improving care quality. Digital health has become a part of our everyday reality.

Clara Campàs Moya concludes, “Emerging health technologies will open the door to a new prevention experience – unnoticeable but highly personalized and effective once assistants will take care of us day and night.”

Asabys Partners is a venture capital firm from Barcelona investing in highly innovative and transformative technologies, focusing on the health-tech and biopharma industries. Driven by the mission of pushing the boundaries of science and medicine, Asabys Partners finances the most disruptive technologies and collaborates with the best talents of our industry.

Don't get left behind. Stay up to date and sign-up for The Sidebar now. (Don’t worry, you can unsubscribe at any time.)

About the author

Artur Olesch

Artur Olesch is a Berlin-based freelance journalist and correspondent for digital health-related topics.

See all articles by this author
Blue Sidekick icon encouraging anyone interested to get in touch with us.

Would you like to talk to us about this article?

We’d love to hear from you! Please share your thoughts, ideas, and questions with Serene at: serene@sidekickhealth.com